10 January 2023 - The OncobiotaLUNG assay is the first blood microbiome driven liquid biopsy with proven effectiveness, including identifying cancer in its earliest stages.
Micronoma announced today that its OncobiotaLUNG assay received the breakthrough device designation from the FDA.